Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: INTERNATIONAL BUSINESS MACHINES CORPORATION
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2019-09-23 to 2020-10-24
Current total value of award: $884836.68
Description: THE OBJECTIVE OF THIS PROJECT IS TO SUPPORT THE FDA IN ITS DETERMINATION OF STANDARDS FOR SUBMISSION OF RWE TO FDA TO INFORM REGULATORY DECISIONS FOR DRUG APPROVAL AND PROVIDE A ROADMAP FOR DEVELOPING SUBMISSION STANDARDS FOR RWE AT FDA.   THE SCOP